On November 6, 2026, an exceptional group of internationally recognized scientists and clinicians will convene in Boston for a one-day meeting focused on one of the most fundamental questions in reproductive and developmental biology: how human eggs activate and begin early embryonic development. The 2026 Activated Egg Symposium, titled “Unique Human Egg Activation Pathways,” is part of a series hosted by the Bedford Research Foundation since 2002 and is designed to foster scientific exchange, spark new collaborations, and bring experts from academia, fertility clinics, and biotechnology together.
The symposium matters because the molecular and cellular mechanisms that shape human egg activation, fertilization, and developmental competence remain poorly understood. Ann A. Kiessling, Director of the Bedford Research Foundation, noted that “we still have fundamental questions about how human eggs develop, and answering them could open new possibilities in reproductive and regenerative medicine.” Those possibilities extend to fertility treatment, assisted reproduction, stem cell science, and developmental medicine, making the meeting’s translational relevance a central draw.
The program will feature presentations spanning ovarian biology, fertilization, calcium signaling, genome stability, cellular reprogramming, stem cell-based models of early development, and the biological foundations of successful embryo development. By uniting leading voices across disciplines and sectors, the symposium aims to foster meaningful dialogue, encourage new partnerships, and accelerate translational progress in fertility and developmental science.
Featured speakers include Evelyn Telfer, Professor and Chair of Reproductive Biology at the University of Edinburgh; Ali H. Brivanlou of The Rockefeller University; Rafael Fissore of the University of Massachusetts Amherst; Ehsan Habibi of the Ottawa Hospital Research Institute and University of Ottawa; Jonathan van Blerkom of the University of Colorado, Boulder; Dietrich M. Egli of Columbia University Irving Medical Center; and Elizebeth Carr, America’s first IVF baby, speaker and advocate. Collectively, they represent pioneering work in ovarian biology, fertilization, egg activation, developmental competence, nuclear transfer, pluripotency, synthetic embryology, and genome stability in early development.
The event offers a rare opportunity for researchers, clinicians, trainees, and innovators to engage directly with leaders whose work has helped define modern reproductive biology, stem cell science, and regenerative medicine. Its focused one-day format is built to maximize scientific exchange, audience engagement, and collaboration, while the cross-sector setting is intended to promote discussion, networking, and new scientific partnerships.
For a field where basic questions about human egg development persist, the symposium’s emphasis on unique activation pathways could help shape the next generation of fertility and regenerative therapies. The participation of scientists who have shaped major advances makes the meeting a significant moment for those seeking to understand the earliest steps of human development.
